Urinary Time- or Dose-Dependent Metabolic Biomarkers of Aristolochic Acid-Induced Nephrotoxicity in Rats

Toxicol Sci. 2017 Mar 1;156(1):123-132. doi: 10.1093/toxsci/kfw244.

Abstract

The metabolic mechanisms underlying aristolochic acid (AA)-induced nephrotoxicity are inconclusive. A Gas Chromatography-Mass Spectrometer (GC-MS)-based metabolomic study was performed to analyze urinary metabolites in AA-treated rats at different dosages (10, 20, and 40 mg/kg) and time points (2, 4, and 6 days). Serum blood urea nitrogen (BUN), creatinine, and kidney injury were significantly changed only on the 6th day in 40 mg/kg AA group, whereas metabolic alternation appeared even on the 2nd day in 10 mg/kg AA group. A total of 84 differential metabolites were identified in 40 mg/kg AA groups time-dependently and 81 in 10, 20, and 40 mg/kg AA groups dose-dependently (6 days) compared with control group. Eight metabolites were selected as potential metabolic biomarkers including methylsuccinic acid, nicotinamide, 3-hydroxyphenylacetic acid, citric acid, creatinine, uric acid, glycolic acid, and gluconic acid. Four of them were dose-dependently altered including methylsuccinic acid, citric acid, creatinine, and 3-hydroxyphenylacetic acid, which were defined as "early metabolic biomarker." The alteration of nicotinamide, uric acid, and gluconic acid was time- and dose-dependent, whereas the change of glycolic acid was time- or dose-independent. The latter 4 metabolites were defined as "late metabolic biomarker" because of the obvious reduction on the 6th day in 40 mg/kg AA group. In summary, the urinary metabolic alterations were more sensitive than conventional biomarkers of renal injury. The identified metabolites suggested pathways of energy metabolism, gut microbiota, and purine metabolism were associated with AA-induced nephrotoxicity time- or dose-dependently. Further investigation was warranted to determine the roles of the 8 potential metabolic biomarkers in AA-induced nephrotoxicity.

Keywords: aristolochic acid; metabolic biomarkers; metabolomics.; nephrotoxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aristolochic Acids / administration & dosage
  • Aristolochic Acids / toxicity*
  • Biomarkers / urine
  • Carcinogens / administration & dosage
  • Carcinogens / toxicity*
  • Citric Acid / urine
  • Creatinine / urine
  • Dose-Response Relationship, Drug
  • Injections, Intraperitoneal
  • Kidney / drug effects*
  • Kidney / metabolism
  • Kidney / pathology
  • Kidney / physiopathology
  • Male
  • Metabolomics / methods
  • Phenylacetates / urine
  • Principal Component Analysis
  • Random Allocation
  • Rats, Wistar
  • Renal Insufficiency / chemically induced*
  • Renal Insufficiency / metabolism
  • Renal Insufficiency / pathology
  • Renal Insufficiency / physiopathology
  • Specific Pathogen-Free Organisms
  • Succinates / urine
  • Toxicokinetics
  • Weight Gain / drug effects

Substances

  • Aristolochic Acids
  • Biomarkers
  • Carcinogens
  • Phenylacetates
  • Succinates
  • Citric Acid
  • aristolochic acid I
  • Creatinine
  • methylsuccinic acid
  • 3-hydroxybenzeneacetic acid